Erratum: Advances in RIPK1 kinase inhibitors

An Erratum on
Advances in RIPK1 kinase inhibitors

by Chen L, Zhang X, Ou Y, Liu M, Yu D, Song Z, Niu L, Zhang L and Shi J (2022). Front. Pharmacol. 13:976435. doi: 10.3389/fphar.2022.976435

Due to a production error, the list of affiliations used for the authors was incorrect. The correct affiliations list is shown below.

Lu Chen^1,2,†, Xiaoqin Zhang^3,†, Yaqing Ou^4,†, Maoyu Liu^1,2,†, Dongke Yu^1,2, Zhiheng Song⁵, Lihong Niu^6,*, Lijuan Zhang^1,2,* and Jianyou Shi^1,2,*

¹Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China

²Personalized Drug Therapy Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China

³Department of Critical Care Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Affiliated Hospital of University of Electronic Science and Technology of China, Chengdu, Sichuan, China

⁴Department of Pharmacy, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu, Sichuan, China

⁵Suzhou University of Science and Technology, Suzhou, Jiangsu, China, 6 Institute of Laboratory Animal Sciences, Academy of Medical Sciences and Sichuan Provincial People’s Hospital, Chengdu, Sichuan, China

The publisher apologizes for this mistake. The original version of this article has been updated.